Stocks · US
TMO
XNYS
Thermo Fisher Scientific, Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E35.92x
P/B4.75x
P/S5.40x
EPS$18.84
ROE13.23%
ROA6.16%
Dividend yield0.26%
EV/EBITDA25.41x
Debt/Equity0.81
Free cash flow$7.3B
Returns and 52-week range
1W-3.39%
1M+6.97%
3M+28.71%
6M+34.13%
1Y+20.85%
YTD+10.81%
52W high$694.33
52W low$435.27
From 52W high-5.44%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 노바티스(ADR) | $267.9B | 39.64 | 3.70 | -12.00% |
| 아스트라제네카 | $242.8B | 109.30 | 17.94 | -2.51% |
| 유나이티드헬스 그룹 | $339.8B | 24.06 | 3.45 | -5.24% |
| 암젠 | $217.9B | 24.92 | 18.64 | -7.92% |
| 머크 | $344.3B | 108.50 | 8.21 | -5.58% |
| 길리어드 사이언스 | $179.3B | — | 15.16 | -4.48% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.